Hyperliquid Strategies Inc.
PURR$8.97−3.13% 1D
$3.0152-week range$14.76
Updated . Prices are snapshots and may be delayed.
Hyperliquid Strategies Inc. price chart
−12.45% over 7D
$10.28
$8.96
Oct 19
Oct 20
AI Outlook for Hyperliquid Strategies Inc.
Neutral posture- Long-term trend+21.6% vs 200-day average
- Medium-term trend-18.5% vs 50-day average
- Averages50-day above 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Hyperliquid Strategies Inc. performance
1D
−3.1%
7D
−13.7%
30D
−36.3%
90D
+26.7%
1Y
+130.0%
About Hyperliquid Strategies Inc.
Hyperliquid Strategies Inc. is a biotechnology company based in the United States, listed on NASDAQ since 2025 (ticker PURR).
Hyperliquid Strategies Inc. market data
What is the price of Hyperliquid Strategies Inc. today?
Hyperliquid Strategies Inc. (PURR) is at $8.97, −3.13% on the day.
What is the 52-week range of Hyperliquid Strategies Inc.?
Over the past year Hyperliquid Strategies Inc. has traded between $3.01 and $14.76. It is currently 51% of the way up that range.
Similar stocks
MRNA
Moderna Inc
$226.89+4.4%
IBRX
Immunitybio Inc
$8.42−8.4%
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
$3.61+2.3%
SLN
Silence Therapeutics Plc American Depository Share
$19.58−0.0%
TCRT
Alaunos Therapeutics, Inc. Common Stock
$3.13+5.0%
BCRX
BioCryst Pharmaceuticals, Inc.
$8.07+3.9%
IOVA
Iovance Biotherapeutics, Inc.
$14.21+3.0%
IRON
Disc Medicine, Inc.
$78.93+8.6%
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.








